+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Biosimilar"

From
Biologics - Global Strategic Business Report 2026 - Product Thumbnail Image

Biologics - Global Strategic Business Report 2026

  • Report
  • November 2026
  • 495 Pages
  • Global
From
From
Biologics Safety Testing - Global Strategic Business Report 2026 - Product Thumbnail Image

Biologics Safety Testing - Global Strategic Business Report 2026

  • Report
  • November 2026
  • 208 Pages
  • Global
From
Biopharmaceuticals - Global Strategic Business Report 2026 - Product Thumbnail Image

Biopharmaceuticals - Global Strategic Business Report 2026

  • Report
  • November 2026
  • 757 Pages
  • Global
From
Monoclonal Antibodies - Global Strategic Business Report 2026 - Product Thumbnail Image

Monoclonal Antibodies - Global Strategic Business Report 2026

  • Report
  • November 2026
  • 561 Pages
  • Global
From
From
From
From
From
From
Self-Administered Biologics Market Report 2026 - Product Thumbnail Image

Self-Administered Biologics Market Report 2026

  • Report
  • July 2026
  • 250 Pages
  • Global
From
Antibody Discovery Services Market Global Report 2026 - Product Thumbnail Image

Antibody Discovery Services Market Global Report 2026

  • Report
  • April 2026
  • 250 Pages
  • Global
From
Biologics Sterile Fill-Finish Services Market Report 2026 - Product Thumbnail Image

Biologics Sterile Fill-Finish Services Market Report 2026

  • Report
  • March 2026
  • 250 Pages
  • Global
From
From
Lymphocyte Activating Gene 3 (LAG3) Antibody Market Report 2026 - Product Thumbnail Image

Lymphocyte Activating Gene 3 (LAG3) Antibody Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Loading Indicator

The Biosimilar market is a subset of the biotechnology industry that focuses on the development and production of biologic drugs that are similar to existing biologic drugs. Biosimilars are created using a process called recombinant DNA technology, which involves the manipulation of genetic material to create a drug that is similar to an existing biologic drug. Biosimilars are typically used to treat chronic conditions such as cancer, rheumatoid arthritis, and multiple sclerosis. Biosimilars are typically cheaper than their brand-name counterparts, making them an attractive option for patients and healthcare providers. Some companies in the Biosimilar market include Amgen, Biocon, Celltrion, Dr. Reddy's Laboratories, Mylan, Pfizer, Sandoz, and Teva Pharmaceuticals. Show Less Read more